GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Shanghai Haoyuan Chemexpress Co Ltd (SHSE:688131) » Definitions » Shares Outstanding (EOP)

Shanghai Haoyuan Chemexpress Co (SHSE:688131) Shares Outstanding (EOP) : 211 Mil (As of Dec. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Shanghai Haoyuan Chemexpress Co Shares Outstanding (EOP)?

Shares outstanding are shares that have been authorized, issued, and purchased by investors and are held by them. Shanghai Haoyuan Chemexpress Co's shares outstanding for the quarter that ended in Dec. 2024 was 211 Mil.

Shanghai Haoyuan Chemexpress Co's quarterly shares outstanding stayed the same from Sep. 2024 (211 Mil) to Dec. 2024 (211 Mil).

Shanghai Haoyuan Chemexpress Co's annual shares outstanding increased from Dec. 2023 (211 Mil) to Dec. 2024 (211 Mil). It means Shanghai Haoyuan Chemexpress Co issued new shares from Dec. 2023 to Dec. 2024 .


Shanghai Haoyuan Chemexpress Co Shares Outstanding (EOP) Historical Data

The historical data trend for Shanghai Haoyuan Chemexpress Co's Shares Outstanding (EOP) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shanghai Haoyuan Chemexpress Co Shares Outstanding (EOP) Chart

Shanghai Haoyuan Chemexpress Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Shares Outstanding (EOP)
Get a 7-Day Free Trial Premium Member Only Premium Member Only 152.96 203.99 208.78 210.54 210.93

Shanghai Haoyuan Chemexpress Co Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Shares Outstanding (EOP) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 210.54 210.54 210.54 210.93 210.93

Competitive Comparison of Shanghai Haoyuan Chemexpress Co's Shares Outstanding (EOP)

For the Drug Manufacturers - Specialty & Generic subindustry, Shanghai Haoyuan Chemexpress Co's Shares Outstanding (EOP), along with its competitors' market caps and Shares Outstanding (EOP) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Shanghai Haoyuan Chemexpress Co's Shares Outstanding (EOP) Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Shanghai Haoyuan Chemexpress Co's Shares Outstanding (EOP) distribution charts can be found below:

* The bar in red indicates where Shanghai Haoyuan Chemexpress Co's Shares Outstanding (EOP) falls into.


;
;

Shanghai Haoyuan Chemexpress Co Shares Outstanding (EOP) Calculation

Shares outstanding are shares that have been authorized, issued, and purchased by investors and are held by them. They have voting rights and represent ownership in the corporation by the person that holds the shares. They should be distinguished from treasury shares, which are shares held by the corporation itself, having no exercisable rights.

Shares outstanding can be calculated as either basic or fully diluted. The fully diluted shares outstanding count includes diluting securities, such as options, warrants or convertibles.

Please note: GuruFocus named Shares Outstanding (EOP) is the shares for that end of period. It is usually used to calculate balance sheet related items, such as Book Value per Share, etc. While Shares Outstanding (Diluted Average) and Shares Outstanding (Basic Average) are the weighted average shares over a period of time (a year, a quarter, or so). They are usually used to calculate income statement or cashflow statement related items, such as Earnings per Share (Diluted), etc.


Shanghai Haoyuan Chemexpress Co  (SHSE:688131) Shares Outstanding (EOP) Explanation

A company may buy back shares or issue shares in any fiscal period. If a company buys back shares, we should observe that the total number of shares decline. If the company issues new shares, the number of shares outstanding increases.

Usually the presence of treasury shares and a history of buyback are good indicators that company has competitive advantage. But studies have shown that companies usually buy back at wrong time. Buying back shares below its intrinsic value increases value for remaining shareholders. Buying back overvalued shares destroys value for existing shareholders.


Be Aware

Warren Buffett looks for consistency and upward long term trend. Because of share repurchase it is possible for net earnings trend to differ from EPS trend. He preferred net income over EPS. The companies with durable competitive advantage companies report higher % net earnings to total revenues.

Important: If a company is showing net earnings history greater than 20% on total revenues, it is probably benefiting from a long term competitive advantage.

If net earnings is less than 10%, likely to be in a highly competitive business.


Shanghai Haoyuan Chemexpress Co Shares Outstanding (EOP) Related Terms

Thank you for viewing the detailed overview of Shanghai Haoyuan Chemexpress Co's Shares Outstanding (EOP) provided by GuruFocus.com. Please click on the following links to see related term pages.


Shanghai Haoyuan Chemexpress Co Business Description

Traded in Other Exchanges
N/A
Address
No. 2, Lane 720, Cailun Road, Room 501, Pilot Free Trade Zone, Shanghai, CHN, 201203
Shanghai Haoyuan Chemexpress Co Ltd focuses on providing small molecule and new modalities CDMO services for both pharmaceutical and biotech clients. The company's comprehensive CRO & CDMO platform is engaged in the research and development, manufacturing and supply of regulatory starting materials, novel building blocks, intermediates, reference compounds, APIs and drug products. It is a one-stop service platform to support client's projects from early drug discovery, process development to commercialization. The company is committed to delivering high-quality products and CMC services to clients across the entire life cycle of drug development.
Executives
Mei Kui Core technical personnel

Shanghai Haoyuan Chemexpress Co Headlines

No Headlines